PharmaCyte Biotech, Inc. Income Statement
PMCB|14 years of annual SEC 10-K data (FY2012-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 14 fiscal years. All figures from audited SEC 10-K filings.
PharmaCyte Biotech, Inc. reported $0 in revenue and $333,763 in net income for FY2025. Revenue has declined at a 54.1% compound annual rate over the past 3 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.20 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $12.2K | $12.2K | $66.6K | $126.0K |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | $0 | $9.6K | $9.6K | $19.4K | $32.1K |
| Gross Profit | - | - | - | - | - | - | - | - | - | $0 | $2.5K | $2.5K | $47.2K | $93.9K |
| SG&A Expense | $6.1M | $1.1M | $1.1M | $418.1K | $1.2M | $1.4M | $1.8M | $744.8K | $2.3M | $1.9M | $617.3K | $617.3K | $416.2K | $237.0K |
| R&D Expense | $407.4K | $468.5K | $690.9K | $916.2K | $301.2K | $460.1K | $2.0M | $1.2M | $1.4M | $323.5K | $0 | - | - | - |
| Operating Income | -$8.5M | -$6.5M | -$4.4M | -$3.6M | -$3.8M | -$4.1M | -$7.0M | -$4.4M | -$6.1M | -$19.0M | -$1.7M | -$1.7M | -$1.9M | - |
| Interest Expense | - | - | $509 | $3.0K | $453 | $0 | - | $1.5K | $1.2K | $20.0K | $154.4K | $112.7K | $230.1K | $171.7K |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | - | - | - |
| Net Income | $333.8K | -$4.3M | -$4.2M | -$3.6M | -$3.8M | -$4.1M | -$6.8M | -$4.4M | -$6.1M | -$27.3M | -$1.6M | -$1.6M | -$1.9M | -$1.4M |
| EPS (Basic) | -$1.80 | -$0.22 | -$0.27 | -$2.45 | - | - | - | - | - | - | - | $0.00 | -$0.01 | $0.00 |
| EPS (Diluted) | -$1.80 | -$0.22 | -$0.27 | -$2.45 | -$4.23 | $0.00 | -$0.01 | -$0.01 | -$0.01 | -$0.05 | $0.00 | - | - | - |
| Shares Outstanding | 8.0M | 16.8M | 20.7M | 1.6M | 1.1M | 1.2B | 1.0B | 905.3M | 781.2M | 732.8M | 690.6M | 482.1M | 416.3M | - |
| Gross Margin | - | - | - | - | - | - | - | - | - | - | 20.9% | 20.9% | 70.9% | 74.5% |
| Operating Margin | - | - | - | - | - | - | - | - | - | - | -13851.7% | -13851.7% | -2928.5% | - |
| Profit Margin | - | - | - | - | - | - | - | - | - | - | -13142.3% | -13142.3% | -2853.6% | -1109.3% |